ArticleCurrent microbiology2026
Molecular Characterization and Microscopic Analysis of Biofilms in Clinical Isolates of Acinetobacter baumannii.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nosocomial infections are a major health problem worldwide. The increasing time patients spend in hospitals has led to an increase in mortality. Acinetobacter baumannii is an opportunistic pathogen that is a significant factor in nosocomial infections. The main aim of the current study was to investigate biofilm and pathogenicity-related genes among multidrug-resistant A. baumannii strains (n = 54) obtained from patients with respiratory infections. ERIC-PCR was also used to determine their molecular typing correlation. Disk diffusion and MIC methods were used to test antibiotic susceptibility. Biofilm formation was evaluated using crystal violet staining and SEM imaging. In this study, 96.30% of isolates formed biofilms, and 59.25% were strong biofilm producers. The most prevalent biofilm-related genes were pgaC (98.15%), pgaB (92.6%), and pgaA (79.6%), followed by epsA and ompA (74.1%). The isolates demonstrated high resistance to imipenem (100%), cefotaxime (98.15%), followed by cefepime, ceftazidime, levofloxacin, and piperacillin/tazobactam (96.3%). The presence of antibiotic-resistant genes was as follows: bla
Indexed as
Identifiers
42329428What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.